SCHEMBL22929957

SCHEMBL22929957

c1cc(-c2ccc3c(c2)-c2ccccc2-c2ccccc2-c2ccccc2-3)cc(-c2ncc3c(n2)-c2ccccc2-c2ccccc2-c2cc(-n4c5ccccc5c5ccccc54)ccc2-3)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 6/20 0.32
IRAK1 P51617 11/20 0.32
ATM Q13315 2/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
APAF1 O14727 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
THRB P10828 1/20 0.31
XBP1 P17861 1/20 0.31
PTBP1 P26599 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
GALK1 P51570 1/20 0.31
BLM P54132 1/20 0.31
SMAD3 P84022 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22929930 0.82 MEN1 (0.34) ATML3MBTL1MEN1APAF1NPC1
SCHEMBL22929958 0.82 ATM (0.31) ATML3MBTL1KDM4EMEN1APAF1
SCHEMBL20926842 0.82 KDM4E (0.35) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL22929955 0.80 ATM (0.35) ATML3MBTL1KDM4EMEN1APAF1
SCHEMBL20926845 0.80 KDM4E (0.37) ATML3MBTL1KDM4ELMNAMAPT
SCHEMBL17297257 0.80 ATM (0.42) ATML3MBTL1KDM4EMEN1APAF1
SCHEMBL17953742 0.79 KDM4E (0.37) IRAK4ATML3MBTL1KDM4ENPC1
SCHEMBL17953744 0.79 KDM4E (0.37) IRAK4ATML3MBTL1KDM4ENPC1
SCHEMBL20926843 0.79 NPC1 (0.31) NPC1LMNAMAPTRAB9ASMN1; SMN2
SCHEMBL17991288 0.78 KDM4E (0.33) ATML3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910577-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910577-B2 Organic electroluminescent materials and devices CACNA2D2, ORC3, ANO2 IRAK4 4794/4885IRAK1 4824/4885ATM 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.